Papers
List our Papers
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.
Salvatori E, Lione L, Compagnone M, Pinto E, Conforti A, Ciliberto G, Aurisicchio L, Palombo F.
npj Vaccines 2022 volume 7, 15.
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models.
Conforti A et al.
Mol Ther 2022 Jan 5;30(1):311-326. doi: 10.1016/j.ymthe.2021.09.011.
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model
Compagnone M, Pinto E, Salvatori E, Lione L, Conforti A, Marchese S, Ravà M, Ryan K, Hall Y, Rayner E, Salguero FJ, Paterson J, Iannacone M, De Francesco R, Aurisicchio L, Palombo F. – Vaccines (Basel). 2022 Jul 25;10(8):1178. doi: 10.3390/vaccines10081178. PMID: 35893826; PMCID: PMC9332309.
Linear DNA amplicons as a novel cancer vaccine strategy
Conforti A, Salvatori E, Lione L, Compagnone M, Pinto E, Shorrock C, Hayward JA, Sun Y, Liang BM, Palombo F, Viscount B, Aurisicchio L. – Exp Clin Cancer Res. 2022 Jun 6;41(1):195. doi: 10.1186/s13046-022-02402-5. PMID: 35668533; PMCID: PMC9169303.
Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections.
Luberto L, Neroni B, Gandini O, Fiscarelli EV, Salvatori G, Roscilli G, Marra E.
Front Microbiol 2021 Dec 15;12:789774. doi: 10.3389/fmicb.2021.789774